Create Medic Income Statement

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	13,572	13,030	12,585	12,257	11,698	10,830
Revenue Growth (YoY)	4.97%	3.54%	2.68%	4.78%	8.02%	-0.12%
Cost of Revenue	7,516	7,326	7,107	6,883	6,438	5,753
Gross Profit	6,056	5,704	5,478	5,374	5,260	5,077
Selling, General & Admin	4,970	5,011	4,675	4,636	4,393	4,092
Operating Expenses	4,970	5,011	4,675	4,636	4,393	4,092
Operating Income	1,086	693	803	738	867	985
Interest Expense	-9	-10	-10	-7	-6	-7
Interest & Investment Income	39	42	35	42	43	33
Currency Exchange Gain (Loss)	-59	3	26	26	84	-60
Other Non Operating Income (Expenses)	21	23	23	11	26	5
EBT Excluding Unusual Items	1,078	751	877	810	1,014	956
Gain (Loss) on Sale of Investments	-	-29	-24	-	-75	-3
Gain (Loss) on Sale of Assets	-30	297	-5	4	-5	-4
Asset Writedown	-143	-23	-	-	-	-
Other Unusual Items	197	89	56	22	31	34
Pretax Income	1,102	1,085	904	836	965	983
Income Tax Expense	340	245	750	376	305	324
Net Income	762	840	154	460	660	659
Net Income to Common	762	840	154	460	660	659
Net Income Growth	-14.29%	445.46%	-66.52%	-30.30%	0.15%	-9.10%
Shares Outstanding (Basic)	9	9	9	9	9	9
Shares Outstanding (Diluted)	9	9	9	9	9	9
Shares Change (YoY)	-2.91%	-3.17%	0.05%	0.03%	-1.83%	-0.55%
EPS (Basic)	89.37	95.31	16.92	50.56	72.57	71.13
EPS (Diluted)	87.82	95.31	16.92	50.56	72.57	71.13
EPS Growth	-11.72%	463.32%	-66.54%	-30.33%	2.02%	-8.60%
Free Cash Flow	-	1,865	263	201	949	1,021
Free Cash Flow Per Share	-	211.60	28.89	22.09	104.34	110.21
Dividend Per Share	20.000	37.000	37.000	37.000	37.000	37.000
Dividend Growth	-45.95%	-	-	-	-	-
Gross Margin	44.62%	43.78%	43.53%	43.84%	44.96%	46.88%
Operating Margin	8.00%	5.32%	6.38%	6.02%	7.41%	9.10%
Profit Margin	5.62%	6.45%	1.22%	3.75%	5.64%	6.08%
Free Cash Flow Margin	-	14.31%	2.09%	1.64%	8.11%	9.43%
EBITDA	1,758	1,329	1,391	1,338	1,329	1,390
EBITDA Margin	12.95%	10.20%	11.05%	10.92%	11.36%	12.83%
D&A For EBITDA	672	636	588	600	462	405
EBIT	1,086	693	803	738	867	985
EBIT Margin	8.00%	5.32%	6.38%	6.02%	7.41%	9.10%
Effective Tax Rate	30.85%	22.58%	82.97%	44.98%	31.61%	32.96%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.